Items in cart [0] Questions? Call 888-624-8373

PAPERBACK list:$15.00 Web:$13.50 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters Display this book on your site! Related Titles Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health Science and Security in a Post 9/11 World: A Report Based on Regional Discussions Between the Science and Security Communities Other Related Titles Discussions of the Committee on Daubert Standards: Summary of Meetings (2006) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 33   E-mail  Facebook  Digg  Stumble  Twitter More Page 33 Front Matter (R1-R10) 1 Introduction (1-2) 2 Overview of Key Supreme Court Decisions (3-6) 3 The Legal Landscape Post-Daubert (7-10) 4 Evidence Synthesis: The Question of Causation (11-16) 5 Areas Needing Further Study (17-20) Selected References (21-22) Appendix A Committee Biographies (23-32) Appendix B Meeting Agenda (33-36)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 33
Appendix B Meeting Agenda First Meeting of the Committee on Daubert Standards January 27, 2005 Agenda 9:30 Handling Science in the PPA Litigation A Judge's Perspective Barbara J. Rothstein, Director, Federal Judicial Center 11:15 Wrestling with Causation in Tort Litigation Steven Goodman, Associate Professor of Oncology, Pediatrics, Epidemiology and Biostatistics, Johns Hopkins School of Medicine Michael D. Green, Bess and Walter Williams Distinguished Chair in Law, Wake Forest University Law School 12:00 Lunch 1:00 Breast Implants Panel of Expert Scientists Margaret Berger, Suzanne J. and Norman Miles Professor of Law, Brooklyn Law School Joe S. Cecil, Project Director, Program on Scientific and Technical Evidence, Federal Judicial Center 33

OCR for page 34
DISCUSSIONS OF THE COMMITTEE ON DAUBERT STANDARDS 2:45 Media Perspective: Academic Science and Drug Development David Korn, Senior Vice President, Association of American Medical Colleges Barry Meier, The New York Times 4:00 Improving the Gatekeeper's Decision-Making Shirley S. Abrahamson, Chief Justice, Wisconsin Supreme Court Marina Corodemus, Superior Court of New Jersey Barbara J. Rothstein, Director, Federal Judicial Center 5:15 Adjourn Second Meeting of the Committee on Daubert Standards March 27, 2005 Agenda 1:30 Daubert Revisited ­ Areas Needing Further Study Committee Co-Chairs: Margaret Berger, Suzanne J. and Norman Miles Professor of Law, Brooklyn Law School Douglas Weed, Chief, Office of Preventive Oncology, National Cancer Institute, NIH 1. Evidence Synthesis in Science and Law ­ A consider- ation of the different approaches used by scientists, lawyers, and judges in the selection, summarization, and interpretation of scientific evidence. 2. Involvement of Scientists in the Legal Process ­ A consideration of how the Daubert decision has changed the involvement, role, and responsibilities of scientists in the courtroom, and opportunities and challenges for 34

OCR for page 35
Meeting Agenda more multi-disciplinary education and research in science and law. 3. Availability of Information ­ A consideration of how courts and the public respond when scientific informa- tion is not forthcoming, whether because pertinent studies were never undertaken, or were conducted but never disclosed, or were sealed in settlement/secrecy agreements. 5:30 Adjourn 35

OCR for page 36

Representative terms from entire chapter:

law school